Sugar molecules in our bodies can disable proteins that help cancer cells proliferate. A new study involving high-resolution structures determined from data collected at the APS reveals how one such molecule deglycates a protein. These findings can serve as the basis for structure-based and in silico drug design targeting that molecule.